Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07332741 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Study acronym: FIM+DASH
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from Mar 2029 to Jun 30, 2030 Primary endpoint(s) modified · Recruitment opened · Completion pushed from Jun 2029 to Sep 2030 · 4 morev2 Show 7 more changesShow less
    • Primary endpoint(s) modified
    • Recruitment opened
    • Completion pushed from Jun 2029 to Sep 2030
    • Start date changed from estimate of Mar 1, 2026 to May 22, 2026
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints revised (3)
    • Study sites revised (4)

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?
Trial Details
NCT Number NCT07332741
Lead Sponsor University of Illinois at Chicago
Conditions Hypertension, Hypertension (HTN), Obesity & Overweight
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov